Back
SemiLEDs Corp. 10K Form
Sell
32
LEDS
SemiLEDs Corp.
Last Price:
$1.58
Seasonality Move:
1.22%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-04-12 | 10Q | LEDS/SemiLEDs Corp. Quarterly |
| 2024-01-12 | 10Q | LEDS/SemiLEDs Corp. Quarterly |
| 2023-07-07 | 10Q | LEDS/SemiLEDs Corp. Quarterly |
| 2023-04-12 | 10Q | LEDS/SemiLEDs Corp. Quarterly |
| 2023-01-06 | 10Q | LEDS/SemiLEDs Corp. Quarterly |
| 2022-07-12 | 10Q | LEDS/SemiLEDs Corp. Quarterly |
Receive LEDS News And Ratings
See the #1 stock for the next 7 days that we like better than LEDS
LEDS Financial Statistics
Sales & Book Value
| Annual Sales: | $43M |
|---|---|
| Cash Flow: | $330K |
| Price / Cash Flow: | 5.98 |
| Annual Sales: | $0.25 |
| Price / Book: | 6.88 |
Profitability
| EPS (TTM): | -0.15090 |
|---|---|
| Net Income (TTM): | $-1.3M |
| Gross Margin: | $2.4M |
| Return on Equity: | -47.26% |
| Return on Assets: | -7.65% |
SemiLEDs Corp. Earnings Forecast
Key SemiLEDs Corp. Financial Ratios
-
The Gross Profit Margin over the past 18 years for LEDS is 5.65%.
-
The Selling, General & Administrative Expenses for LEDS have been equal to 6.68% of Gross Profit Margin.
-
The Research & Development expenses have been 2.68% of Revenue.
-
The Net Earning history of LEDS is -2.63% of Total Revenues.
-
Per Share Earnings over the last 18 years have been positive in 11 years.
SemiLEDs Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Semiconductors & Semiconductor Equipment |
| Sector: | Information Technology |
| Current Symbol: | LEDS |
| CUSIP: | 816645 |
| Website: | semileds.com |
Debt
| Debt-to-Equity Ratio: | 1.84 |
|---|---|
| Current Ratio: | 0.94 |
| Quick Ratio: | 0.45 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
LEDS Technical Analysis vs Fundamental Analysis
Sell
32
SemiLEDs Corp. (LEDS)
is a Sell
Is SemiLEDs Corp. a Buy or a Sell?
-
SemiLEDs Corp. stock is rated a SellThe current SemiLEDs Corp. [LEDS] share price is $1.73. The Score for LEDS is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.